Position in PTGX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$300,220,852
+$42,076,964 QoQ
Shares Held
2,449,183
0.0% QoQ
Ownership
3.78%
of shares outstanding
% of Portfolio
37.59%
of 13F equity value
Holder Rank
#9
of 341 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JOHNSON & JOHNSON holds $757,781,542 across 11 Biotechnology names. PTGX ranks #1 (39.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
This page
|
2,449,183 | $300,220,852 | |
| 2 | NBTX |
Nanobiotix S.A.
|
5,623,816 | $212,017,863 | |
| 3 | MGTX |
MeiraGTx Holdings plc
|
6,641,064 | $89,720,774 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
1,784,517 | $74,360,823 | |
| 5 | CTNM |
Contineum Therapeutics, Inc.
|
1,979,173 | $32,438,645 | |
| 6 | LEGN |
Legend Biotech Corp
|
814,586 | $23,525,243 | |
| 7 | XNCR |
Xencor Inc
|
748,062 | $12,043,798 | |
| 8 | FATE |
Fate Therapeutics Inc
|
3,379,064 | $9,123,472 |
All Filings in PTGX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,220,852 | 2,449,183 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $258,143,888 | 2,449,183 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $213,911,643 | 2,449,183 | Shares | Defined | 2026-03-18 | |
| 2025-09-30 | $162,699,226 | 2,449,183 | Shares | Defined | 2026-03-18 | |
| 2025-06-30 | $135,366,344 | 2,449,183 | Shares | Defined | 2025-07-22 | |
| 2025-03-31 | $118,442,489 | 2,449,183 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $94,538,463 | 2,449,183 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $110,213,235 | 2,449,183 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $84,864,190 | 2,449,183 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $70,854,864 | 2,449,183 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $56,159,766 | 2,449,183 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $40,852,372 | 2,449,183 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $67,646,434 | 2,449,183 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $56,331,209 | 2,449,183 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $26,720,586 | 2,449,183 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $20,646,612 | 2,449,183 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $19,373,037 | 2,449,183 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $57,996,653 | 2,449,183 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $83,762,058 | 2,449,183 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $43,399,522 | 2,449,183 | Shares | Defined | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||